21
A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer
Condition(s):Castration-resistant Prostate CancerLast Updated:June 12, 2018Recruiting
Metastatic Prostate Carcinoma in the Soft Tissue: 113 Clinical Trials, Page 3 of 12
Hide Studies Not Open or Pending
22
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
Condition(s):Progressive Metastatic Prostate CancerLast Updated:August 14, 2020Active, not recruiting
23
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Condition(s):Metastatic Prostate CancerLast Updated:July 24, 2020Active, not recruiting
24
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Condition(s):Prostate Cancer Metastatic; Castration-resistant Prostate CancerLast Updated:February 25, 2019Not yet recruiting
25
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
Condition(s):Hormone-Sensitive Prostate CancerLast Updated:July 30, 2020Recruiting
26
18F-FDG PET/CT and Whole Body MRI for Staging and Response Prediction in Castration-resistant Prostate Cancer Patients Receiving Enzalutamide
Condition(s):Prostate Cancer MetastaticLast Updated:February 18, 2020Recruiting
27
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Condition(s):Adenocarcinoma of the Prostate; Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Soft Tissue Metastases; Stage IV Prostate CancerLast Updated:January 3, 2020Completed
28
PROMOTE: Identifying Predictive Markers of Response for Prostate Cancer
Condition(s):Prostate CancerLast Updated:March 24, 2020Recruiting
29
Impact of Atorvastatin on Prostate Cancer Progression During ADT
Condition(s):Metastatic Prostate Cancer; Recurrent Prostate CancerLast Updated:September 11, 2019Recruiting
30
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:April 21, 2020Active, not recruiting